{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T21:22:03Z","timestamp":1787433723086,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bbadis.2026.168367","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:19:58Z","timestamp":1784042398000},"page":"168367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SOCS5 suppresses antitumor immunity in colorectal cancer by promoting IFNAR1 ubiquitylation and type I interferon response"],"prefix":"10.1016","volume":"1872","author":[{"given":"Chengpeng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujing","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bbadis.2026.168367_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101174","article-title":"Global colorectal cancer burden in 2020 and projections to 2040","volume":"14","author":"Xi","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168367_bb0010","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.bbadis.2026.168367_bb0015","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.7150\/ijbs.64077","article-title":"Immunotherapy in colorectal cancer: current achievements and future perspective","volume":"17","author":"Fan","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.bbadis.2026.168367_bb0020","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1007\/s00262-023-03520-5","article-title":"PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies","volume":"72","author":"Lin","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168367_bb0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s13277-011-0264-4","article-title":"SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues","volume":"33","author":"Yoon","year":"2012","journal-title":"Tumour Biol."},{"issue":"6636","key":"10.1016\/j.bbadis.2026.168367_bb0030","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2026.168367_bb0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.immunol.22.091003.090312","article-title":"The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response","volume":"22","author":"Alexander","year":"2004","journal-title":"Annu. Rev. Immunol."},{"issue":"15","key":"10.1016\/j.bbadis.2026.168367_bb0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.febslet.2008.05.039","article-title":"Increased cytoplasmic levels of CIS, SOCS1, SOCS2, or SOCS3 are required for nuclear translocation","volume":"582","author":"Lee","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2026.168367_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-065X.2008.00659.x","article-title":"Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins","volume":"224","author":"Dimitriou","year":"2008","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.bbadis.2026.168367_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4161\/cc.6.7.4037","article-title":"Knocking off SOCS genes in the mammary gland","volume":"6","author":"Sutherland","year":"2007","journal-title":"Cell Cycle (Georgetown, Tex)"},{"issue":"11","key":"10.1016\/j.bbadis.2026.168367_bb0055","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41419-022-05361-z","article-title":"SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1\u03b1-dependent mitochondrial damage","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168367_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41698-024-00545-6","article-title":"SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2026.168367_bb0065","first-page":"143","article-title":"lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway","volume":"35","author":"Yan","year":"2020","journal-title":"Cancer Biother. Radiopharm."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168367_bb0070","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/cas.14021","article-title":"Epigenetic silencing of SOCS5 potentiates JAK-STAT signaling and progression of T-cell acute lymphoblastic leukemia","volume":"110","author":"Sharma","year":"2019","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168367_bb0075","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/carcin\/bgz121","article-title":"MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK\/STAT3 signaling pathway by targeting SOCS5","volume":"41","author":"Hu","year":"2020","journal-title":"Carcinogenesis"},{"issue":"6","key":"10.1016\/j.bbadis.2026.168367_bb0080","doi-asserted-by":"crossref","first-page":"14125","DOI":"10.1080\/21655979.2022.2081463","article-title":"SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy","volume":"13","author":"Yu","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.bbadis.2026.168367_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J. Big Data"},{"issue":"8","key":"10.1016\/j.bbadis.2026.168367_bb0090","first-page":"1497","article-title":"Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023"},{"key":"10.1016\/j.bbadis.2026.168367_bb0095","article-title":"Landscape of microsatellite instability across 39 cancer types","volume":"2017","author":"Bonneville","year":"2017","journal-title":"JCO Precis. Oncol."},{"issue":"10","key":"10.1016\/j.bbadis.2026.168367_bb0100","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bbadis.2026.168367_bb0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12929-023-00930-6","article-title":"Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8(+) T cells through PI3K\/AKT\/mTOR signaling pathway in colorectal cancer","volume":"30","author":"Li","year":"2023","journal-title":"J. Biomed. Sci."},{"issue":"17","key":"10.1016\/j.bbadis.2026.168367_bb0110","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1158\/0008-5472.CAN-23-1167","article-title":"WNK1 interaction with KEAP1 promotes NRF2 stabilization to enhance the oxidative stress response in hepatocellular carcinoma","volume":"84","author":"Li","year":"2024","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbadis.2026.168367_bb0115","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153167","article-title":"Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-\u03b3-stimulated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2026.168367_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.606489","article-title":"The role of structure in the biology of interferon signaling","volume":"11","author":"Walter","year":"2020","journal-title":"Front. Immunol."},{"issue":"45","key":"10.1016\/j.bbadis.2026.168367_bb0125","doi-asserted-by":"crossref","first-page":"46614","DOI":"10.1074\/jbc.M407082200","article-title":"Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor","volume":"279","author":"Kumar","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bbadis.2026.168367_bb0130","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1093\/emboj\/cdg524","article-title":"SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor","volume":"22","author":"Kumar","year":"2003","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bbadis.2026.168367_bb0135","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1083\/jcb.200706034","article-title":"Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis","volume":"179","author":"Kumar","year":"2007","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bbadis.2026.168367_bb0140","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.virs.2022.08.004","article-title":"CK1\u03b1 upregulates the IFNAR1 expression to prompt the anti-HBV effect of type I IFN in hepatoma carcinoma cells","volume":"37","author":"Xiong","year":"2022","journal-title":"Virol. Sin."},{"issue":"4","key":"10.1016\/j.bbadis.2026.168367_bb0145","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.18632\/oncotarget.6616","article-title":"Emodin potentiates the antiproliferative effect of interferon \u03b1\/\u03b2 by activation of JAK\/STAT pathway signaling through inhibition of the 26S proteasome","volume":"7","author":"He","year":"2016","journal-title":"Oncotarget"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:25:50Z","timestamp":1787430350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0925443926002309"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168367","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SOCS5 suppresses antitumor immunity in colorectal cancer by promoting IFNAR1 ubiquitylation and type I interferon response","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168367"}}